Physician profile
Jared Leventhal
NPI 1144670522
$3,169.42
in general payments reported to CMS, 2019-2025
22 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $751 · 2021: $817 · 2022: $318 · 2023: $303 · 2024: $146 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $543.40 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $475.01 | 2019-2023 | Lifevest |
| Astellas Pharma US INC | $360.20 | 2019-2021 | |
| Amgen INC. | $255.82 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $248.22 | 2020-2023 | Eliquis, Camzyos |
| Abbott Laboratories | $209.71 | 2019-2020 | |
| Abiomed | $150.62 | 2021 | |
| Novartis Pharmaceuticals Corporation | $145.03 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.47 | 2021-2022 | |
| Boston Scientific Corporation | $107.16 | 2020-2023 | Watchman Access System |
| Medtronic Vascular, INC. | $102.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.93 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $62.07 | 2021-2025 | Farxiga, Wainua |
| Chiesi USA, INC. | $50.58 | 2020-2021 | |
| Bridgebio Pharma, INC. | $49.59 | 2025 | Attruby |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $40.66 | 2021 | |
| Pfizer INC. | $38.00 | 2023-2025 | |
| Irhythm Technologies, INC. | $30.87 | 2024 | Zio Xt Patch, Zio Monitor |
| Sensible Medical Innovations INC | $30.17 | 2025 | Reds System |
| Merck Sharp & Dohme LLC | $25.15 | 2025 | Verquvo |
| Scpharmaceuticals INC. | $21.85 | 2024 | |
| Siemens Medical Solutions USA, INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Leventhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.